GCSAML (Gene)

Organism:

Homo sapiens

Synonyms:C1orf150, ENTREZ:148823, GCSAML, HGNC:29583, NM_001281834, NM_001281835, NM_001281836, NM_001281837, NM_001281838, NM_001281853, NM_145278, NP_001268763, NP_001268764, NP_001268765, NP_001268766, NP_001268767, NP_001268782, NP_660321, XM_024453417, XP_024309185, germinal center associated signaling and motility like

Id:ENSG00000169224

Hgnc:HGNC:29583

Entrez:148823

Ensembl:ENSG00000169224

Description:germinal center associated signaling and motility like

This gene encodes a protein thought to be a signaling molecule associated with germinal centers, the sites of proliferation and differentiation of mature B lymphocytes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View GCSAML's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with GCSAML.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using GCSAML.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for GCSAML.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GCSAML.

Results found

Linked to

	Label	Description
	GSE152441,GSE152442 6 V 4 FOLIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225523 GSE225527 FOXO1 overexpression CAR 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE221577 PIK3R1 knockout 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE159893 2 V 1 GENISTEIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE229663 GSE229666 menin inhibition 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 1 V 3 DECITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE152441,GSE152442 1 V 5 FOLIC ACID HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE182181 1 V 0 RICOLINOSTAT HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE152441,GSE152442 6 V 4 FOLIC ACID HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE185200 GSE185202 L-13 Ali-BL 0 v 6 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE225523 GSE225527 FOXO1 overexpression CAR 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE221577 PIK3R1 knockout 1 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE159893 2 V 1 GENISTEIN HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE218060 decitabine T cell 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE229663 GSE229666 menin inhibition 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE218060 1 V 3 DECITABINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE152441,GSE152442 1 V 5 FOLIC ACID HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE182181 1 V 0 RICOLINOSTAT HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.